Approval · Notice of Compliance 8290 · 2006
FENOFIBRATE MICRO: Notice of Compliance 8290
Issued October 2, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8290
- Date
- October 2, 2006
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- Lipid metabolism regulator
- Canadian reference product
- LIPIDIL MICRO (Laboratoires Fournier S.A.S.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FENOFIBRATE MICRO | 02286092 | Cancelled Post Market |
| FENOFIBRATE MICRO | 02286084 | — |
Medicinal ingredients
- FENOFIBRATE 200 MG per CAP
- FENOFIBRATE 67 MG per CAP